|
|
|
Alexion in Deal with Boston Hospital
|
Business New Haven
3/6/2000
By: Kristine Hansen
|
NEW HAVEN - Alexion Pharmaceuticals Inc. (NASDAQ: AMXN) has signed a research and licensing agreement with Brigham & Women's Hospital in Boston for the development of experimental drugs for control of inflammation. According to terms of the agreement, Alexion will hold worldwide marketing rights to anti-inflammatory drugs resulting from the collaboration.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
